Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal based on its concern that the benefits of the drug may no longer outweigh its risks. This is the first time the agency … Continue reading TODAY, THE FDA REQUESTED THAT OPANA ER BE REMOVED FROM THE MARKET DUE TO ADDICTION & DEATH. IT’S ABOUT TIME!!!!!!!!!!